Pre- and Neonatal Imprinting on Immunological Homeostasis and Epithelial Barrier Integrity by Escherichia coli Nissle 1917 Prevents Allergic Poly-Sensitization in Mice
Language English Country Switzerland Media electronic-ecollection
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
33679699
PubMed Central
PMC7927790
DOI
10.3389/fimmu.2020.612775
Knihovny.cz E-resources
- Keywords
- BALB/c, Escherichia coli Nissle 1917, allergic poly-sensitization, germ-free, hygiene hypothesis, mouse model, mucosal tolerance,
- MeSH
- Allergens immunology MeSH
- Hypersensitivity immunology MeSH
- Antigens, Plant immunology MeSH
- Betula immunology MeSH
- Epithelial Cells immunology MeSH
- Escherichia coli immunology MeSH
- Germ-Free Life immunology MeSH
- Homeostasis immunology MeSH
- Immune System immunology MeSH
- Poaceae immunology MeSH
- Mice, Inbred BALB C MeSH
- Mice MeSH
- Probiotics administration & dosage MeSH
- Pollen immunology MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Allergens MeSH
- Antigens, Plant MeSH
A steady rise in the number of poly-sensitized patients has increased the demand for effective prophylactic strategies against multi-sensitivities. Probiotic bacteria have been successfully used in clinics and experimental models to prevent allergic mono-sensitization. In the present study, we have investigated whether probiotic bacteria could prevent poly-sensitization by imprinting on the immune system early in life. We used two recombinant variants of probiotic Escherichia coli Nissle 1917 (EcN): i) EcN expressing birch and grass pollen, poly-allergen chimera construct (EcN-Chim), and ii) an "empty" EcN without allergen expression (EcN-Ctrl). Conventional mice (CV) were treated with either EcN-Chim or EcN-Ctrl in the last week of the gestation and lactation period. Gnotobiotic mice received one oral dose of either EcN-Chim or EcN-Ctrl before mating. The offspring from both models underwent systemic allergic poly-sensitization and intranasal challenge with recombinant birch and grass pollen allergens (rBet v 1, rPhl p 1, and rPhl p 5). In the CV setting, the colonization of offspring via treatment of mothers reduced allergic airway inflammation (AAI) in offspring compared to poly-sensitized controls. Similarly, in a gnotobiotic model, AAI was reduced in EcN-Chim and EcN-Ctrl mono-colonized offspring. However, allergy prevention was more pronounced in the EcN-Ctrl mono-colonized offspring as compared to EcN-Chim. Mono-colonization with EcN-Ctrl was associated with a shift toward mixed Th1/Treg immune responses, increased expression of TLR2 and TLR4 in the lung, and maintained levels of zonulin-1 in lung epithelial cells as compared to GF poly-sensitized and EcN-Chim mono-colonized mice. This study is the first one to establish the model of allergic poly-sensitization in gnotobiotic mice. Using two different settings, gnotobiotic and conventional mice, we demonstrated that an early life intervention with the EcN without expressing an allergen is a powerful strategy to prevent poly-sensitization later in life.
See more in PubMed
Calderon MA, Cox L, Casale TB, Moingeon P, Demoly P. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol (2012) 129(4):929–34. 10.1016/j.jaci.2011.11.019 PubMed DOI
Forkel S, Beutner C, Heetfeld A, Fuchs T, Schön MP, Geier J, et al. . Allergic Rhinitis to Weed Pollen in Germany: Dominance by Plantain, Rising Prevalence, and Polysensitization Rates over 20 Years. Int Arch Allergy Immunol (2020) 181(2):128–35. 10.1159/000504297 PubMed DOI
Ha EK, Baek JH, Lee SY, Park YM, Kim WK, Sheen YH, et al. . Association of Polysensitization, Allergic Multimorbidity, and Allergy Severity: A Cross-Sectional Study of School Children. Int Arch Allergy Immunol (2016) 171(3–4):251–60. 10.1159/000453034 PubMed DOI
Migueres M, Davila I, Frati F, Azpeitia A, Jeanpetit Y, Lheritier-Barrand M, et al. . Types of sensitization to aeroallergens: definitions, prevalences and impact on the diagnosis and treatment of allergic respiratory disease. Clin Trans Allergy (2014) 4:16. 10.1186/2045-7022-4-16 PubMed DOI PMC
Raciborski F, Bousqet J, Namysłowski A, Krzych-Fałta E, Tomaszewska A, Piekarska B, et al. . Dissociating polysensitization and multimorbidity in children and adults from a Polish general population cohort. Clin Trans Allergy (2019) 9(1):4. 10.1186/s13601-019-0246-y PubMed DOI PMC
Silvestri M, Rossi GA, Cozzani S, Pulvirenti G, Fasce L. Age-dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic children. Ann Allergy Asthma Immunol (1999) 83(4):335–40. 10.1016/S1081-1206(10)62674-9 PubMed DOI
Bousquet J, Hejjaoui A, Becker WM, Cour P, Chanal I, Lebel B, et al. . Clinical and immunologic reactivity of patients allergic to grass pollens and to multiple pollen species: I. Clinical and immunologic characteristics. J Allergy Clin Immunol (1991) 87(3):737–46. 10.1016/0091-6749(91)90397-7 PubMed DOI
Ciprandi G, De Amici M, Giunta V, Marseglia GL. Comparison of serum specific IgE and skin prick test in polysensitized patients. Int J Immunopathol Pharmacol (2010) 23(4):1293–5. 10.1177/039463201002300438 PubMed DOI
Ciprandi G, Incorvaia C, Puccinelli P, Soffia S, Scurati S, Frati F. Polysensitization as a challenge for the allergist: the suggestions provided by the Polysensitization Impact on Allergen Immunotherapy studies. Expert Opin Biol Ther (2011) 11(6):715–22. 10.1517/14712598.2011.576246 PubMed DOI
Hatzler L, Panetta V, Lau S, Wagner P, Bergmann RL, Illi S, et al. . Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol (2012) 130(4):894–901.e5. 10.1016/j.jaci.2012.05.053 PubMed DOI
Movérare R, Westritschnig K, Svensson M, Hayek B, Bende M, Pauli G, et al. . Different IgE Reactivity Profiles in Birch Pollen-Sensitive Patients from Six European Populations Revealed by Recombinant Allergens: An Imprint of Local Sensitization. Int Arch Allergy Immunol (2002) 128(4):325–35. 10.1159/000063855 PubMed DOI
Anto JM, Bousquet J, Akdis M, Auffray C, Keil T, Momas I, et al. . Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes. J Allergy Clin Immunol (2017) 139(2):388–99. 10.1016/j.jaci.2016.12.940 PubMed DOI
Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol (2001) 108(5 Suppl):S147–334. 10.1067/mai.2001.118891 PubMed DOI
Nelson HS. Multiallergen immunotherapy for allergic rhinitis and asthma. J Allergy Clin Immunol (2009) 123(4):763–9. 10.1016/j.jaci.2008.12.013 PubMed DOI
Larsen JN, Broge L, Jacobi H. Allergy immunotherapy: the future of allergy treatment. Drug Discov Today (2016) 21(1):26–37. 10.1016/j.drudis.2015.07.010 PubMed DOI
Kim KW, Kim EA, Kwon BC, Kim ES, Song TW, Sohn MH, et al. . Comparison of allergic indices in monosensitized and polysensitized patients with childhood asthma. J Korean Med Sci (2006) 21(6):1012–6. 10.3346/jkms.2006.21.6.1012 PubMed DOI PMC
Renz H, Adkins BD, Bartfeld S, Blumberg RS, Farber DL, Garssen J, et al. . The neonatal window of opportunity—early priming for life. J Allergy Clin Immunol (2018) 141(4):1212–4. 10.1016/j.jaci.2017.11.019 PubMed DOI PMC
Torow N, Hornef MW. The Neonatal Window of Opportunity: Setting the Stage for Life-Long Host-Microbial Interaction and Immune Homeostasis. J Immunol (2017) 198(2):557. 10.4049/jimmunol.1601253 PubMed DOI
Lambrecht BN, Hammad H. The immunology of the allergy epidemic and the hygiene hypothesis. Nat Immunol (2017) 18(10):1076–83. 10.1038/ni.3829 PubMed DOI
Hill CJ, Lynch DB, Murphy K, Ulaszewska M, Jeffery IB, O’Shea CA, et al. . Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort. Microbiome (2017) 5(1):4–. 10.1186/s40168-016-0213-y PubMed DOI PMC
Schabussova I, Hufnagl K, Tang ML, Hoflehner E, Wagner A, Loupal G, et al. . Perinatal maternal administration of Lactobacillus paracasei NCC 2461 prevents allergic inflammation in a mouse model of birch pollen allergy. PLoS One (2012) 7(7):6. 10.1371/journal.pone.0040271 PubMed DOI PMC
Schwarzer M, Repa A, Daniel C, Schabussova I, Hrncir T, Pot B, et al. . Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization. Allergy (2011) 66(3):368–75. 10.1111/j.1398-9995.2010.02488.x PubMed DOI
Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, et al. . A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol (2008) 122(4):788–94. 10.1016/j.jaci.2008.07.011 PubMed DOI
Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, et al. . Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol (2009) 123(2):335–41. 10.1016/j.jaci.2008.11.019 PubMed DOI
Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet (2001) 357(9262):1076–9. 10.1016/S0140-6736(00)04259-8 PubMed DOI
Schwarzer M, Srutkova D, Schabussova I, Hudcovic T, Akgun J, Wiedermann U, et al. . Neonatal colonization of germ-free mice with Bifidobacterium longum prevents allergic sensitization to major birch pollen allergen Bet v 1. Vaccine (2013) 31(46):5405–12. 10.1016/j.vaccine.2013.09.014 PubMed DOI
Sonnenborn U. Escherichia coli strain Nissle 1917—from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties. FEMS Microbiol Lett (2016) 363(19):fnw212–fnw. 10.1093/femsle/fnw212 PubMed DOI
Sarate PJ, Heinl S, Poiret S, Drinić M, Zwicker C, Schabussova I, et al. . E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitization. Mucosal Immunol (2019) 12(1):132–44. 10.1038/s41385-018-0084-6 PubMed DOI
Pablos I, Wildner S, Asam C, Wallner M, Gadermaier G. Pollen Allergens for Molecular Diagnosis. Curr Allergy Asthma Rep (2016) 16:31. 10.1007/s11882-016-0603-z PubMed DOI PMC
Schabussova I, Hufnagl K, Wild C, Nutten S, Zuercher AW, Mercenier A, et al. . Distinctive anti-allergy properties of two probiotic bacterial strains in a mouse model of allergic poly-sensitization. Vaccine (2011) 29(10):1981–90. 10.1016/j.vaccine.2010.12.101 PubMed DOI
Schwarzer M, Makki K, Storelli G, Machuca-Gayet I, Srutkova D, Hermanova P, et al. . Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition. Science (2016) 351(6275):854–7. 10.1126/science.aad8588 PubMed DOI
Kozakova H, Schwarzer M, Tuckova L, Srutkova D, Czarnowska E, Rosiak I, et al. . Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization. Cell Mol Immunol (2016) 13(2):251–62. 10.1038/cmi.2015.09 PubMed DOI PMC
Winkler B, Baier K, Wagner S, Repa A, Eichler HG, Scheiner O, et al. . Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin Exp Allergy (2002) 32(1):30–6. 10.1046/j.0022-0477.2001.01214.x PubMed DOI
Skevaki C, Hudemann C, Matrosovich M, Möbs C, Paul S, Wachtendorf A, et al. . Influenza-derived peptides cross-react with allergens and provide asthma protection. J Allergy Clin Immunol (2018) 142(3):804–14. 10.1016/j.jaci.2017.07.056 PubMed DOI
Hufnagl K, Winkler B, Focke M, Valenta R, Scheiner O, Renz H, et al. . Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice. J Allergy Clin Immunol (2005) 116(2):370–6. 10.1016/j.jaci.2005.04.002 PubMed DOI
Srutkova D, Schwarzer M, Hudcovic T, Zakostelska Z, Drab V, Spanova A, et al. . Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner. PLoS One (2015) 10(7):e0134050. 10.1371/journal.pone.0134050 PubMed DOI PMC
Helps SC, Thornton E, Kleinig TJ, Manavis J, Vink R. Automatic nonsubjective estimation of antigen content visualized by immunohistochemistry using color deconvolution. Appl Immunohistochem Mol Morphol AIMM (2012) 20(1):82–90. 10.1097/PAI.0b013e31821fc8cd PubMed DOI
Mustafa HN, El Awdan SA, Hegazy GA, Abdel Jaleel GA. Prophylactic role of coenzyme Q10 and Cynara scolymus L on doxorubicin-induced toxicity in rats: Biochemical and immunohistochemical study. Indian J Pharmacol (2015) 47(6):649–56. 10.4103/0253-7613.169588 PubMed DOI PMC
Warm K, Lindberg A, Lundbäck B, Rönmark E. Increase in sensitization to common airborne allergens among adults – two population-based studies 15 years apart. Allergy Asthma Clin Immunol (2013) 9(1):20–. 10.1186/1710-1492-9-20 PubMed DOI PMC
Silvestri M, Oddera S, Crimi P, Rossi GA. Frequency and specific sensitization to inhalant allergens within nuclear families of children with asthma and/or rhinitis. Ann Allergy Asthma Immunol (1997) 79(6):512–6. 10.1016/S1081-1206(10)63058-X PubMed DOI
Biedermann T, Winther L, Till SJ, Panzner P, Knulst A, Valovirta E. Birch pollen allergy in Europe. Allergy (2019) 74(7):1237–48. 10.1111/all.13758 PubMed DOI
Amenyogbe N, Kollmann TR, Ben-Othman R. Early-Life Host–Microbiome Interphase: The Key Frontier for Immune Development. Front Pediatrics (2017) 5(111). 10.3389/fped.2017.00111 PubMed DOI PMC
Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science (New York NY) (2016) 352(6285):539–44. 10.1126/science.aad9378 PubMed DOI PMC
Verhasselt V. Oral tolerance in neonates: from basics to potential prevention of allergic disease. Mucosal Immunol (2010) 3(4):326–33. 10.1038/mi.2010.25 PubMed DOI
Mennini M, Dahdah L, Artesani MC, Fiocchi A, Martelli A. Probiotics in Asthma and Allergy Prevention. Front Pediatrics (2017) 5:165. 10.3389/fped.2017.00165 PubMed DOI PMC
Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic Mechanisms of Action. Ann Nutr Metab (2012) 61(2):160–74. 10.1159/000342079 PubMed DOI
Gardlik R, Palffy R, Celec P. Recombinant probiotic therapy in experimental colitis in mice. Folia Biologica (2012) 58(6):238–45. PubMed
He L, Yang H, Liu F, Chen Y, Tang S, Ji W, et al. . Escherichia coli Nissle 1917 engineered to express Tum-5 can restrain murine melanoma growth. Oncotarget (2017) 8(49):85772–82. 10.18632/oncotarget.20486 PubMed DOI PMC
Zhang Y, Zhang Y, Xia L, Zhang X, Ding X, Yan F, et al. . Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein. Appl Environ Microbiol (2012) 78(21):7603–10. 10.1128/AEM.01390-12 PubMed DOI PMC
Adam E, Delbrassinne L, Bouillot C, Reynders V, Mailleux A-C, Muraille E, et al. . Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-dependent pathway. Eur J Immunol (2010) 40(7):1995–2005. 10.1002/eji.200939913 PubMed DOI
Fujimura KE, Lynch SV. Microbiota in Allergy and Asthma and the Emerging Relationship with the Gut Microbiome. Cell Host Microbe (2015) 17(5):592–602. 10.1016/j.chom.2015.04.007 PubMed DOI PMC
Chung KF. Airway microbial dysbiosis in asthmatic patients: A target for prevention and treatment? J Allergy Clin Immunol (2017) 139(4):1071–81. 10.1016/j.jaci.2017.02.004 PubMed DOI
Stokholm J, Blaser MJ, Thorsen J, Rasmussen MA, Waage J, Vinding RK, et al. . Maturation of the gut microbiome and risk of asthma in childhood. Nat Commun (2018) 9(1):141. 10.1038/s41467-018-03150-x PubMed DOI PMC
Asarnoj A, Hamsten C, Wadén K, Lupinek C, Andersson N, Kull I, et al. . Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study. J Allergy Clin Immunol (2016) 137(3):813–21.e7. 10.1016/j.jaci.2015.09.052 PubMed DOI PMC
Lynch SV, Boushey HA. The Microbiome and Development of Allergic disease. Curr Opin Allergy Clin Immunol (2016) 16(2):165–71. 10.1097/ACI.0000000000000255 PubMed DOI PMC
Santos KD, Traebert J, Piovezan AP, Silva JD. Relevance of the first thousand days of life to the development of wheezing in children aged 6–7 years. Allergologia Immunopathologia (2020) 48(3):270–80. 10.1016/j.aller.2019.12.007 PubMed DOI
Schaub B, Prescott SL. 1 - The Maturation of Immune Function in Pregnancy and Early Childhood. In: Wahn U, Sampson HA, editors. Allergy, Immunity and Tolerance in Early Childhood. Amsterdam: Academic Press; (2016). p. 1–17. 10.1016/B978-0-12-420226-9.00001-2 DOI
Hufnagl K, Focke M, Gruber F, Hufnagl P, Loupal G, Scheiner O, et al. . Airway inflammation induced after allergic poly-sensitization can be prevented by mucosal but not by systemic administration of poly-peptides. Clin Exp Allergy (2008) 38(7):1192–202. 10.1111/j.1365-2222.2008.02992.x PubMed DOI
Tang ML, Martino DJ. Oral immunotherapy and tolerance induction in childhood. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol (2013) 24(6):512–20. 10.1111/pai.12100 PubMed DOI
Burks AW, Jones SM, Wood RA, Fleischer DM, Sicherer SH, Lindblad RW, et al. . Oral Immunotherapy for Treatment of Egg Allergy in Children. New Engl J Med (2012) 367(3):233–43. 10.1056/NEJMoa1200435 PubMed DOI PMC
Taniuchi S, Takahashi M, Soejima K, Hatano Y, Minami H. Immunotherapy for cow’s milk allergy. Hum Vaccines Immunother (2017) 13(10):2443–51. 10.1080/21645515.2017.1353845 PubMed DOI PMC
Lara-Villoslada F, Olivares M, Sierra S, Rodríguez JM, Boza J, Xaus J. Beneficial effects of probiotic bacteria isolated from breast milk. Br J Nutr (2007) 98 Suppl 1:S96–100. 10.1017/S0007114507832910 PubMed DOI
Moossavi S, Miliku K, Sepehri S, Khafipour E, Azad MB. The Prebiotic and Probiotic Properties of Human Milk: Implications for Infant Immune Development and Pediatric Asthma. Front Pediatr (2018) 6:197–. 10.3389/fped.2018.00197 PubMed DOI PMC
Westritschnig K, Horak F, Swoboda I, Balic N, Spitzauer S, Kundi M, et al. . Different allergenic activity of grass pollen allergens revealed by skin testing. Eur J Clin Invest (2008) 38(4):260–7. 10.1111/j.1365-2362.2008.01938.x PubMed DOI
Bokanovic D, Aberer W, Hemmer W, Heinemann A, Komericki P, Scheffel J, et al. . Determination of sIgE to rPhl p 1 is sufficient to diagnose grass pollen allergy. Allergy (2013) 68(11):1403–9. 10.1111/all.12263 PubMed DOI
Flicker S, Steinberger P, Ball T, Krauth MT, Verdino P, Valent P, et al. . Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity. J Allergy Clin Immunol (2006) 117(6):1336–43. 10.1016/j.jaci.2006.02.012 PubMed DOI
Bickert T, Trujillo-Vargas CM, Duechs M, Wohlleben G, Polte T, Hansen G, et al. . Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways. Int Arch Allergy Immunol (2009) 149(3):219–30. 10.1159/000199717 PubMed DOI
Satitsuksanoa P, Jansen K, Głobińska A, van de Veen W, Akdis M. Regulatory Immune Mechanisms in Tolerance to Food Allergy. Front Immunol (2018) 9(2939). 10.3389/fimmu.2018.02939 PubMed DOI PMC
Krogulska A, Borowiec M, Polakowska E, Dynowski J, Młynarski W, Wasowska-Królikowska K. FOXP3, IL-10, and TGF-β Genes Expression in Children with IgE-Dependent Food Allergy. J Clin Immunol (2011) 31(2):205–15. 10.1007/s10875-010-9487-1 PubMed DOI PMC
Böhm L, Maxeiner J, Meyer-Martin H, Reuter S, Finotto S, Klein M, et al. . IL-10 and Regulatory T Cells Cooperate in Allergen-Specific Immunotherapy To Ameliorate Allergic Asthma. J Immunol (2015) 194(3):887. 10.4049/jimmunol.1401612 PubMed DOI
Tunis MC, Marshall JS. Toll-Like Receptor 2 as a Regulator of Oral Tolerance in the Gastrointestinal Tract. Mediators Inflamm (2014) 2014:606383. 10.1155/2014/606383 PubMed DOI PMC
Sturm A, Rilling K, Baumgart DC, Gargas K, Abou-Ghazalé T, Raupach B, et al. . Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling. Infect Immun (2005) 73(3):1452–65. 10.1128/IAI.73.3.1452-1465.2005 PubMed DOI PMC
Grabig A, Paclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, et al. . Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect Immun (2006) 74(7):4075–82. 10.1128/IAI.01449-05 PubMed DOI PMC
Frey A, Lunding LP, Ehlers JC, Weckmann M, Zissler UM, Wegmann M. More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis. Front Immunol (2020) 11:761. 10.3389/fimmu.2020.00761 PubMed DOI PMC
Espinosa V, Rivera A. First Line of Defense: Innate Cell-Mediated Control of Pulmonary Aspergillosis. Front Microbiol (2016) 7:272. 10.3389/fmicb.2016.00272 PubMed DOI PMC
Georas SN, Rezaee F. Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. J Allergy Clin Immunol (2014) 134(3):509–20. 10.1016/j.jaci.2014.05.049 PubMed DOI PMC
Natsume O, Ohya Y. Recent advancement to prevent the development of allergy and allergic diseases and therapeutic strategy in the perspective of barrier dysfunction. Allergol Int (2018) 67(1):24–31. 10.1016/j.alit.2017.11.003 PubMed DOI
Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers (2016) 4(4):e1251384–e. 10.1080/21688370.2016.1251384 PubMed DOI PMC
Cukrowska B, LodInova-ZadnIkova R, Enders C, Sonnenborn U, Schulze J, Tlaskalova-Hogenova H. Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand J Immunol (2002) 55(2):204–9. 10.1046/j.1365-3083.2002.01005.x PubMed DOI
Sonnenborn U, Schulze J. The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic. Microbial Ecol Health Disease (2009) 21(3–4):122–58. 10.3109/08910600903444267 DOI
Wehkamp J, Harder J, Wehkamp K, Meissner B-v, Schlee M, Enders C, et al. . NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by Escherichia coli Nissle 1917: a Novel Effect of a Probiotic Bacterium. Infect Immun (2004) 72(10):5750–8. 10.1128/IAI.72.10.5750-5758.2004 PubMed DOI PMC